ICCC's Q2 sales rise 11.5% y/y, but margins contract. A $2-million legal settlement boosts profit as

ImmuCell Corporation (NASDAQ: ICCC - Get Free Report)'s stock price crossed above its 200-day moving

ImmuCell Corporation (ICCC) Q2 2026 Earnings Call Transcript

ImmuCell (NASDAQ:ICCC) released second-quarter financial results and hosted an earnings call on Frid

ImmuCell NASDAQ: ICCC reported higher second-quarter sales and earnings as domestic demand for its c

ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.20 per share. This is a 233.33 percent incr

PORTLAND, Maine, Aug. 13, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” o

PORTLAND, Maine, Aug. 06, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” o

ImmuCell's main value driver is First Defense. In my view, this is their core franchise and has real

ICCC reports an 11.5% rise in preliminary Q2 sales, driven by robust U.S. demand and improved produc

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), an animal health

PORTLAND, Maine, July 09, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” o

ImmuCell's premium valuation is backed by rising output, First Defense share gains and a sizable unt

ICCC posts record Q1 sales and 34% earnings growth as demand for its First Defense calf-health produ

ImmuCell NASDAQ: ICCC reported a record first quarter of 2026, with management saying the company's

ImmuCell Corporation (ICCC) Q1 2026 Earnings Call Transcript

ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.21 per share. This is a 31.25 percent incre

PORTLAND, Maine, May 14, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or

On May 8, 2026, ImmuCell Corporation and Norbrook Laboratories Limited (incorporated and registered

PORTLAND, Maine, May 07, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or

Goldman Sachs, NextEra Energy and Shopify lead top stock reports, highlighting strong gains, expandi

PORTLAND, Maine, April 13, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), an animal health

PORTLAND, Maine, April 08, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”

ImmuCell Corporation (NASDAQ: ICCC - Get Free Report) crossed above its 200-day moving average durin

PORTLAND, Maine, March 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”

ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.31) per share. This is a 616.67 percent decr

ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell" or the "Company"), an animal health c

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell"), an animal health company that develops, ma

Animal health company ImmuCell receives an Incomplete Letter from the FDA for its Re-Tain NADA. Comp

In seeking FDA approval to bring its innovative Re-Tain® product to market, ImmuCell received Comple

ImmuCell Corporation (NASDAQ:ICCC) ("ImmuCell"), an animal health company that develops, man

ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.02) per share. This is a 77.78 percent incre

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal

PORTLAND, Maine, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCe

ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.06 per share. This is a 130 percent increas

- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing anima

ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.06 per share. This is a 140 percent increas